Skip to main content

and
  1. Article

    Open Access

    Impact of primary resistance to front-line targeted therapy in metastatic renal cell carcinoma on subsequent immune-checkpoint-inhibition

    Synergistic effects have been discussed for tyrosine kinase (TKI) and immune checkpoint inhibitors (ICI). Primary resistance to TKI might disturb subsequent ICI effectiveness. The objective was to investigate,...

    J. H. Börner, S. Neuberger, E. Juengel, S. Ziewers, R. Dotzauer in Discover Oncology (2023)